Artal Group’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-500,000
| Closed | -$1.15M | – | 105 |
|
|
2023
Q2 | $1.15M | Hold |
500,000
| – | – | 0.04% | 86 |
|
|
2023
Q1 | $455K | Hold |
500,000
| – | – | 0.03% | 105 |
|
|
2022
Q4 | $425K | Hold |
500,000
| – | – | 0.02% | 112 |
|
|
2022
Q3 | $409K | Hold |
500,000
| – | – | 0.02% | 121 |
|
|
2022
Q2 | $495K | Hold |
500,000
| – | – | 0.03% | 120 |
|
|
2022
Q1 | $820K | Hold |
500,000
| – | – | 0.03% | 127 |
|
|
2021
Q4 | $1.21M | Hold |
500,000
| – | – | 0.03% | 131 |
|
|
2021
Q3 | $2.42M | Buy |
+500,000
| New | +$2.42M | 0.05% | 125 |
|